5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 339-348

  Patra, Aditi ^a   Deb, Moonmoon ^b   Dahiya, Rajvir ^c   Patra, Samir Kumar ^b  

^a BIDHAN CHANDRA KRISHI VISWAVIDYALAYA   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 Aza 2 deoxycytidine; Apoptosis; CpG hypermethylation; DNMT; Epigenome; Prostate cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CASPASE 3; DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA METHYLATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EPIGENETICS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

EID: 84856284423     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-010-0019-x     Document Type: Article

References (56)

1. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M (1999) A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397:579-583
2. Cervoni N, Bhattacharya S, Szyf M (1999) DNA demethylase is a processive enzyme. J Biol Chem 274:8363-8366 (Pubitemid 29164621)
3. Cervoni N, Detich SS-B, Chakravarti D, Szyf M (2002) The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 277:25026-25031 (Pubitemid 34951806)
4. Chen H, Toyooka S, Gazdar AF, Hsieh JT (2003) Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem 278(5):3121-3130 (Pubitemid 36801222)
5. Christman JK (2002) 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483-5495 (Pubitemid 34983483)
6. Claus R, Almstedt M, Lubbert M (2005) Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol 32:511-520 (Pubitemid 41396428)
7. Dasari VK, Deng D, Perinchery G, Yeh CC, Dahiya R (2002) DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer. J Urol 167(1):335-338 (Pubitemid 34024581)
8. DeSimone J (2004) The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia. Semin Hematol 41:1-3
9. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG (2002) Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295:1079-1082 (Pubitemid 34132239)
10. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS (2003) Tea polyphenol Epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563-7570 (Pubitemid 37466673)
11. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, Davidson NE (1997) Role of estrogen receptor gene demethylation and DNA methyltransferase- DNA adduct formation in 5-aza-2′-deoxycytidine induced cytotoxicity in human breast cancer cells. J Biol Chem 272:32260-32266 (Pubitemid 28011904)
12. Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T (2000) DNA methyltransferase DNMT1 associates with histone deacetylase activity. Nat Genet 24:88-91 (Pubitemid 30041428)
13. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995) Ecadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199
14. Gurumurthy S, Basudevan KM, Rangnekar VM (2001) Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 20:225-243 (Pubitemid 34600970)
15. Hellebrekers DM, Melotte V, Viré E, Langenkamp E, Molema G, Fuks F, Herman JG, Van Criekinge W, Griffioen AW, van Engeland M (2007) Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res 67:4138-4148 (Pubitemid 46815059)
16. Hoffmann K, Brosch G, Loidl P, Jung M (1999) A non-isotopic assay for histone deacetylase activity. Nucleic Acids Res 27:2057-2058 (Pubitemid 29209568)
17. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E, Jaenisch R (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27:31-39 (Pubitemid 32044515)
18. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245-254 (Pubitemid 36278835)
19. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3(6):415-428 (Pubitemid 34587077)
20. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692 (Pubitemid 46273572)
21. Kress C, Thomassin H, Grange T (2001) Local DNA demethylation in vertebrates: how could it be performed and targeted? FEBS Lett 494:135-140 (Pubitemid 32322670)
22. Lavelle D, Vaitkus K, Hankewych M, Singh M, DeSimone J (2006) Effect of 5-aza-2'-deoxycytidine (Dacogen) on covalent histone modifications of chromatin associated with the epsilon-gamma-, and beta-globin promoters in Papio anubis. Exp Hematol 34:339-347
23. Lavelle D, Saunthararajah Y, Desimone J (2008) DNA methylation and mechanism of action of 5-azacytidine. Blood 111:2485 (Pubitemid 351451464)
24. Li LC, Chui R, Nakajima K, Oh BR, Au HC, Dahiya R (2000) Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. Cancer Res 60(3):702-706 (Pubitemid 30094570)
25. Li LC, Zhao H, Nakajima K, Oh BR, Filho LA, Carroll P, Dahiya R (2001) Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol 166(2):705-709 (Pubitemid 32652304)
26. Li LC, Okino ST, Dahiya R (2004) DNA methylation in prostate cancer (review). Biochim Biophys Acta 1704:87-102 (Pubitemid 39195351)
27. Misteli T (2001) Protein dynamics: implications for nuclear architecture and gene expression. Science 291:843-847 (Pubitemid 32120749)
28. Miyaji M, Jin ZX, Yamaoka S et al (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fasmediated apoptosis. J Exp Med 202:249-259 (Pubitemid 41043821)
29. Mollinedo F, Gajate C (2006) Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 9:51-73 (Pubitemid 43928806)
30. Ng H-H, Jeppesen P, Bird A (2000) Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol 20:1394-1406 (Pubitemid 30069259)
31. Nojima D, Li LC, Dharia A, Perinchery G, Ribeiro-Filho L, Yen TS, Dahiya R (2001) CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma. Cancer 92(8):2076-2083 (Pubitemid 32973317)
32. Ohki I, Shimotake N, Fujita N, Jee J-G, Ikegami T, Nakao M, Shirakawa M (2001) Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 105:487-497 (Pubitemid 32520854)
33. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA (2004) Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 279:31735-31744 (Pubitemid 39037845)
34. Patra SK (2008a) Ras regulation of DNA methylation and cancer. Exp Cell Res 314:1193-1201
35. Patra SK (2008b) Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785:182-206
36. Patra SK, Bettuzzi S (2007) Epigenetic DNA methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review). Oncol Rep 17:1279-1290
37. Patra SK, Bettuzzi S (2009) Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2'-deoxycytidine and DNA-demethylation. Biochem (Mosc) 74(6):613-619
38. Patra SK, Patra A (2003) Lipid rafts in cancer metastasis-a working hypothesis. Proc Am Assoc Cancer Res 44:64-65 (1st edition, March 2003)
39. Patra SK, Szyf M (2008) DNA methylation mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FASL and RASSF1A. FEBS J 275:5217-5235
40. Patra SK, Patra A, Dahiya R (2001) Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun 287:705-713 (Pubitemid 32912772)
41. Patra SK, Patra A, Zhao H, Dahiya R (2002) DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 33:163-167
42. Patra SK, Patra A, Zhao H, Carroll P, Dahiya R (2003) Methyl-CpGDNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun 302:759-766 (Pubitemid 36294038)
43. Patra SK, Patra A, Rizzi F, Ghosh TC, Bettuzzi S (2008a) Demethylation of (cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metast Rev 27:315-334
44. Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S (2008b) Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 59 (Suppl 9):217-235
45. Patra SK, Deb M, Patra A (2010) Molecular marks for epigenetic identification of developmental and cancer stem cells. Clin Epigenet. doi:10.1007/s13148-010-0016-0
46. Peterson CL, Logie C (2000) Recruitment of chromatin remodeling machines. J Cell Biochem 78:179-185 (Pubitemid 30415895)
47. Pogribny IP, James SJ (2002) De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett 187:69-75 (Pubitemid 35279334)
48. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M (1999) DNA methylation is a reversible biological signal. Proc Natl Acad Sci USA 96:6107-6112 (Pubitemid 29256627)
49. Rhee I, Jair K-W, Yen R-WC, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB, Schuebel KE (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404:1003-1007 (Pubitemid 30243595)
50. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto S, Dahiya R (2002) Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 94(5):384-390 (Pubitemid 34257482)
51. Sato N, Maehara N, Su GH, Goggins M (2003) Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J Natl Cancer Inst 95:327-330
52. Szyf M, Knox DJ, Milutinovic S, Slack AD, Araujo FD (2000) How does DNA methyltransferase cause oncogenic transformation? Ann NY Acad Sci 910:156-174
53. Taunton J, Hassing CA, Schreiber SL (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408-411 (Pubitemid 26138177)
54. Wijermans P, Lübbert M, Verhoef G, Bosly A, Ravoet C, Andre M, Ferrant A (2000) Low-dose 5-Aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 18:956-965
55. Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5:37-50
56. Zhu J, Yao X (2007) Use of DNA methylation for cancer detection and molecular classification. J Biochem Mol Biol 40:135-141 (Pubitemid 46515190)